Evidence map›Paper›PMID 28921400›Full record

ReviewProbiotics and antimicrobial proteins2019

Gut Microbiota and IL-17A: Physiological and Pathological Responses.

Banafsheh Douzandeh-Mobarrez, Ashraf Kariminik

Abstract readReview
PubMed Publisher
In one paragraph

Review in Probiotics and antimicrobial proteins, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 29 papers.

0numbers the graph read from it
0cells of the map it votes in
29citing papers in PubMed
1.7field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

29 citing papers in PubMed, 73 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Mycology · 2024
    Article
  8. Article
  9. Effects ofFood and waterborne parasitology · 2023
    Article
  10. Article
  11. Review
  12. Review
  13. Article
  14. Review
  15. Review
  16. Bacteroides ovatus-mediated CD27Cellular & molecular immunology · 2022
    Article
  17. Article
  18. Review
  19. Heat-KilledFrontiers in nutrition · 2022
    Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Banafsheh Douzandeh-MobarrezDepartment of Microbiology, Kerman Branch, Islamic Azad University, Kerman, Iran.
Ashraf KariminikDepartment of Microbiology, Kerman Branch, Islamic Azad University, Kerman, Iran. a.kariminik@iauk.ac.ir.
Islamic Azad University Kerman · IR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

IL-17A is a cytokine which is produced by several immune and non-immune cells. The cytokine plays dual roles from protection from microbes and protection from pro-inflammatory based diseases to induction of the pro-inflammatory based diseases. The main mechanisms which lead to the controversial roles of IL-17A are yet to be clarified. Gut microbiota (GM) are the resident probiotic bacteria in the gastrointestinal tracts which have been introduced as a plausible regulator of IL-17A production and functions. This review article describes the recent information regarding the roles played by GM in determination of IL-17A functions outcome.

Indexed as

AnimalsAutoimmune DiseasesDefensinsGastrointestinal MicrobiomeHumansInterleukin-17DefensinsInterleukin-17Gut microbiotaIL-17APro-inflammatory-based diseases

Identifiers

PMID28921400
OpenAlexW2753989617

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.